相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aurora Kinase Inhibition Overcomes Cetuximab Resistance in Squamous Cell Cancer of the Head and Neck
Alexander Hoellein et al.
Oncotarget (2015)
Novel E3 ligase component FBXL7 ubiquitinates and degrades Aurora A, causing mitotic arrest
Tiffany A. Coon et al.
CELL CYCLE (2012)
The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent
Jayasree S. Nair et al.
CELL CYCLE (2012)
Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism
Kevin R. Kelly et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFκB pathway
Ilana Chefetz et al.
CELL CYCLE (2011)
Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer model
Masafumi Kumano et al.
BJU INTERNATIONAL (2010)
Aurora Kinase A Promotes Ovarian Tumorigenesis through Dysregulation of the Cell Cycle and Suppression of BRCA2
Gong Yang et al.
CLINICAL CANCER RESEARCH (2010)
MLN8054, an Inhibitor of Aurora A Kinase, Induces Senescence in Human Tumor Cells Both In vitro and In vivo
Jessica J. Huck et al.
MOLECULAR CANCER RESEARCH (2010)
Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?
Altaf A. Dar et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Essential Roles of mTOR/Akt Pathway in Aurora-A Cell Transformation
Makoto Taga et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2009)
Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells
Phillip Kaestner et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The aurora kinase A regulates GSK-3β in gastric cancer cells
A. A. Dar et al.
ONCOGENE (2009)
Aurora kinases as anticancer drug targets
Oliver Gautschi et al.
CLINICAL CANCER RESEARCH (2008)
Dynamic FoxO transcription factors
Haojie Huang et al.
JOURNAL OF CELL SCIENCE (2007)
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
Mark G. Manfredi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Aurora-A regulation of nuclear factor-κB signaling by phosphorylation of IκBα
Paraskevi Briassouli et al.
CANCER RESEARCH (2007)
Crosstalk between Aurora-A and p53:: Frequent deletion or downregulation of Aurora-A in tumors from p53 null mice
Jian-Hua Mao et al.
CANCER CELL (2007)
Targeted anti-mitotic therapies: can we improve on tubulin agents?
Jeffrey R. Jackson et al.
NATURE REVIEWS CANCER (2007)
Stressing the role of FoxO proteins in lifespan and disease
Armando van der Horst et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Cellular senescence: when bad things happen to good cells
Judith Campisi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function
Farid Gizatullin et al.
CANCER RESEARCH (2006)
Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line
Xiao Xia Wang et al.
CELL RESEARCH (2006)
Mitosis: a matter of getting rid of the right protein at the right time
J Pines
TRENDS IN CELL BIOLOGY (2006)
RNA interference targeting aurora kinase A suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells
T Hata et al.
CANCER RESEARCH (2005)
FoxM1 is required for execution of the mitotic programme and chromosome stability
J Laoukili et al.
NATURE CELL BIOLOGY (2005)
Overexpression and amplification of Aurora-A in hepatocellular carcinoma
YM Jeng et al.
CLINICAL CANCER RESEARCH (2004)
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo
EA Harrington et al.
NATURE MEDICINE (2004)
Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells
C Lindon et al.
JOURNAL OF CELL BIOLOGY (2004)
Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215
QY Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53
H Katayama et al.
NATURE GENETICS (2004)
Suppression of p160ROCK bypasses cell cycle arrest after Aurora-A/STK15 depletion
J Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Aurora-a kinase maintains the fidelity of early and late mitotic events in HeLa cells
T Marumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The cellular geography of aurora kinases
M Carmena et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells
T Hirota et al.
CELL (2003)
FOXO forkhead transcription factors induce G2-M checkpoint in response to oxidative stress
Y Furukawa-Hibi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Control of cell cycle exit and entry by protein kinase B-regulated Forkhead transcription factors
GJPL Kops et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Forkhead transcription factors contribute to execution of the mitotic programme in mammals
B Alvarez et al.
NATURE (2001)
Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation
C Sakakura et al.
BRITISH JOURNAL OF CANCER (2001)
Genetic diversity and disease control in rice
YY Zhu et al.
NATURE (2000)
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
RH Medema et al.
NATURE (2000)
分享论文
